Prevention of cardiovascular effects of endotoxaemia by monoclonal antibodies specific for core endotoxin
- 1 October 1992
- journal article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 79 (10) , 1087-1090
- https://doi.org/10.1002/bjs.1800791033
Abstract
Passive immunization with antibody to the core region of endotoxin (core lipopolysaccharide (LPS)) has been reported to reduce mortality in severe sepsis. A rat model of endotoxaemia that reproduces the hyperdynamic cardiovascular state seen in early sepsis was developed to test monoclonal antibodies specific for core LPS. A thermodilution technique of measuring cardiac output was adapted for use in rats. Twenty‐five animals were anaesthetized and mechanically ventilated with monitoring of central venous pressure and mean arterial pressure. Fluid replacement was adjusted to maintain the central venous pressure. Controls (n = 10) and antibody‐treated animals (n = 5) showed no significant change in cardiac output. Animals given 0.1 mg kg−1 R2 endotoxin over 1 h (n = 5) showed a significant rise in cardiac output of 65 per cent (P < 0.01). This was abolished in rats given both antibody and endotoxin (n = 5). This study provides evidence that a monoclonal antibody against core LPS abolishes the hyperdynamic state induced by endotoxin infusion.Keywords
This publication has 12 references indexed in Scilit:
- Treatment of Gram-negative septic shock with an immunoglobulin preparationCritical Care Medicine, 1991
- A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative SepsisJAMA, 1991
- Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against EndotoxinNew England Journal of Medicine, 1991
- Analysis of serial measurements in medical research.BMJ, 1990
- The Gut Origin Septic States in Blunt Multiple Trauma (ISS = 40) in the ICUAnnals of Surgery, 1987
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- PREVENTION OF GRAM-NEGATIVE SHOCK AND DEATH IN SURGICAL PATIENTS BY ANTIBODY TO ENDOTOXIN CORE GLYCOLIPIDThe Lancet, 1985
- ANTI-LIPOPOLYSACCHARIDE IMMUNOTHERAPY IN MANAGEMENT OF SEPTIC SHOCK OF OBSTETRIC AND GYNAECOLOGICAL ORIGINThe Lancet, 1984
- Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coliNew England Journal of Medicine, 1982
- Measurement of cardiac output in small animals by aortic thermodilutionJournal of Surgical Research, 1982